This inventor holds 1 USPTO granted patent. Top assignee: British Biotech Pharmaceuticals Limited. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Sanjay Ratilal Patel: Innovator in Metalloproteinase Inhibitors
Introduction
Sanjay Ratilal Patel is a notable inventor based in Oxford, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of metalloproteinase inhibitors. His work has implications for various medical applications, showcasing his innovative spirit and dedication to advancing science.
Latest Patents
Sanjay holds a patent for metalloproteinase inhibitors, specifically compounds of formula (I). These compounds are designed to inhibit matrix metalloproteinases, which play a crucial role in various physiological processes. His patent is a testament to his expertise and commitment to addressing complex medical challenges. He has 1 patent to his name.
Career Highlights
Sanjay is currently associated with British Biotech Pharmaceuticals Limited, where he continues to work on groundbreaking research and development projects. His role in the company allows him to collaborate with other talented professionals in the field, further enhancing his contributions to biotechnology.
Collaborations
Some of his notable coworkers include Mark Whittaker and Christopher David Floyd. Their collaboration fosters a dynamic environment for innovation and research, leading to advancements in the pharmaceutical industry.
Conclusion
Sanjay Ratilal Patel's work in metalloproteinase inhibitors exemplifies the impact of innovative thinking in biotechnology. His contributions not only advance scientific knowledge but also hold promise for future medical breakthroughs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile